Ingersoll Rand
0.52 %
-11.06 %
Yet to be announced
Company Overview
Ingersoll Rand Inc. provides mission-critical air, fluid, energy, specialty vehicle and medical technologies. It operates through two segments, Industrial Technologies and Services, and Precision and Science Technologies. The company's products are used in medical, laboratory, industrial manufacturing, water and wastewater, chemical processing, and chemical processing.
Revenue Sources
PassBased on review of Ingersoll Rand's SEC filings and financial statements, the company's revenue is primarily derived from the manufacture and sale of industrial equipment and related services. There is no evidence of revenue from prohibited sources like alcohol, gambling, pornography, or interest-based financial services.
Reliance on Interest
| Reporting Date | Total Revenue | Total Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| March 31, 2025 | $1.72b | $1.48b | - | $61.2m | 0.00% | 4.15% |
| Dec. 31, 2024 | $1.9b | $1.58b | - | $61.8m | 0.00% | 3.91% |
| Sept. 30, 2024 | $1.86b | $1.57b | - | $63.8m | 0.00% | 4.07% |
| June 30, 2024 | $1.81b | $1.59b | - | $53.8m | 0.00% | 3.39% |
Analysis of the last four quarters shows that interest expenses as a percentage of total expenses has remained well below the 5% threshold. The company's interest expense is primarily related to operational financing rather than interest-based revenue generation.
Operational Ethics
PassBased on available information from company disclosures and public sources, there is no evidence of significant ongoing collaboration with entities involved in human rights violations. The company maintains standard business operations globally but without notable controversial partnerships.
Comments